Mitotoxins: Growth factor-targeted cytotoxic molecules

Progress in Growth Factor Research

Volumn 2, Issue 4, 1990, Pages 223-236

  Lappi, Douglas A ^a   Baird, Andrew ^a  

^a Whittier Institute for Diabetes   (United States)

Author keywords

epidermal growth factor; fibroblast growth factor; Growth factor; immunotoxin; interleukins; mitotoxin; nerve growth factor; transforming growth factor

Indexed keywords

BACTERIA (MICROORGANISMS);

BACTERIAL TOXIN; CYTOTOXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; IMMUNOTOXIN; INTERLEUKIN DERIVATIVE; NERVE GROWTH FACTOR; RIBOSOME PROTEIN; SOMATOMEDIN C; TRANSFERRIN;

ANIMAL; HUMAN; REVIEW;

ANIMAL; BACTERIAL TOXINS; CYTOTOXINS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTORS; HUMAN; IMMUNOTOXINS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKINS; NERVE GROWTH FACTORS; RIBOSOMAL PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFERRIN;

EID: 0025526244     PISSN: 09552235     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-2235(90)90020-K     Document Type: Article

References (86)

1. Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin
2. Potentiation of cytotoxic activity of immunotoxins on cultured human cells
3. Enhancement by a synthetic isoprenoid of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin
4. The complete primary structure of protein synthesis inhibitor II from barley seeds
5. Thyrotropin-releasing hormone-diphtheria toxin-related polypeptide conjugates
6. Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues
7. HeLa cell mutants resistant to epidermal growth factor ricin A chain conjugate
8. An epidermal growth factor-ricin A chain (EGF-RTA)-resistant mutant and an epidermal growth factor—Pseudomonas endotoxin (EGF-PE)-resistant mutant have distinct phenotypes
9. Blood clearance and organ distribution and tissue concentration of native, homopolymerized and IgG-conjugated ribosome-inactivating proteins
10. Selective elimination of fibroblasts from pancreatic islet monolayers by basic fibroblast growth factor-saporin mitotoxin
11. Functional impact of attachment and purification in the short-term culture of human pancreatic islets
12. Nucleotide sequence of cDNA coding for saporin-6, a type-1 ribosome-inactivating protein from Saponaria officinalis
13. Killing of K562 cells with conjugates between human transferrin and a ribosome-inactivating protein (SO-6)
14. Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats
15. Kinetics of cytotoxicity induced by immunotoxins
16. T-lymphocyte killing by T101-ricin A-chain immunotoxins: pH-dependent potentiation with lysosomotropic amines
17. Epidermal growth factor-toxin A chain conjugates: EGF-ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic
18. Structure-activity relationships in diphtheria toxin and Pseudomonas aeruginosa exotoxin A
19. Primary amino acid sequence of alpha-trichosanthin and molecular models for abrin A-chain and alpha-trichosanthin
20. B cell stimulatory factor (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens
21. Selective destruction of nerve growth factor receptor-bearing cells in vitro using a hybrid toxin composed of ricin A chain and a moroclonal antibody against the nerve growth factor receptor
22. The site of action of six different ribosome-inactivating proteins from plants on eukaryotic ribosomes: the RNA N-glycosidase activity of the proteins
23. Adenovirus-induced release of epidermal growth factor and Pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocytosis
24. Antitumor effects of an immunotoxin made with Pseudomonas exotoxin in a nude mouse model of human ovarian cancer
25. Use of immunotoxin to inhibit proliferating human corneal endothelium
26. Interferon beta2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells
27. Basic FGF-SAP mitotoxin in the hippocampus: specific lethal effect on cells expressing the basic FGF receptor (Abstract)
28. Amino acid sequence of Mirabilis antiviral protein, total synthesis of its gene and expression in Escherichia coli
29. Long-term inhibition of cellular proliferation by immunotoxins
30. The role of binding ligand in toxic hybrid proteins: A comparison of EGF-ricin, EGF-ricin-A-chain, and ricin
31. Toxic ligand conjugates as tools in the study of receptor-ligand interactions
32. Immunotoxins: A clinical review of their use in the treatment of malignancies
33. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2)
34. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin
35. Functional domains of Pseudomonas exotoxin indentified by deletion analysis of the gene expressed in E. coli
36. Mutant KB cells with decreased EGF receptor expression: Biochemical characterization
37. Complete amino acid sequence of luffin-a, a ribosome-inactivating protein from the seeds of Luffa cylindrica
38. Anti-transferrin receptor immunotoxin inhibits proliferating human retinal pigment epithleial cells
39. Domain II mutants of Pseudomonas exotoxin deficient in translocation
40. Autocrine generation and requirement of BSF-2/IL-6 for multiple myeloma
41. Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo
42. Prolongation of cardiac allograft survival in murine recipients treated with a diphtheria toxin-related interleukin 2 fusion protein
43. Thioridazine enhances lysosomal accumulation of epidermal growth factor and toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin
44. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor
45. Biological and chemical characterization of basic FGF-saporin mitotoxin
46. Role of basic fibroblast growth factor in vascular lesion formation
47. Cardiac allograft survival in mice treated with IL-2PE40
48. Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli
49. Interleukin-2 (IL2) PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL2 receptor
50. Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates
51. The amino acid sequence of a ribosome-inactivating protein from Saponaria officinalis seeds
52. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain
53. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6
54. Inhibition by ricin of protein synthesis in vitro
55. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells
56. Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins
57. Reduced turnover of the elongation factor EF-1-ribosome complex after treatment with the protein synthesis inhibitor II from barley seeds
58. Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin
59. Characterization of the human B cell stimulatory factor 1 receptor
60. Pseudomonas exotoxin: Chimeric toxins
61. Cytotoxic activity of a recombinant fusion protein between insulin-like growth factor I and Pseudomonas exotoxin
62. Growth factors and other ligands
63. Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hematopoietic progenitor cells
64. Characterization of the somatomedin-C/insulin-like growth factor I (SM-C/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by SM-C/IGF-I and insulin
65. Entry of the toxic proteins abrin, modeccin, ricin and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles
66. A new cytotoxin specific for the target cells of corticotropin-releasing factor
67. Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin
68. Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugate
69. A cytotoxic epidermal growth factor cross-linked to diphtheria toxin A-fragment
70. EGF-ricin A conjugates: Kinetic profiles of cytotoxic effects and resistant cell variants
71. Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells
72. Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin
73. Cell-specific cytotoxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells
74. Cytotoxic activities of a fusion protein comprised of TGF α and Pseudomonas exotoxin
75. Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates
76. Killing of cultured hepatocytes by conjugates of asialofetuin and EGF linked to the A chains of ricin or diphtheria toxin
77. Ribosome-inactivating proteins up to date
78. Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree)
79. Effects of anti-epidermal growth factor (EGF) receptor antibodies and an anti-EGF receptor recombinant-ricin A chain immunoconjugate on growth of human cells
80. An immunotoxin composed of monoclonal anti-thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: Potent antitumor effects in vitro and in vivo
81. Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor
82. Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation
83. Destruction of sympathetic neurons in vivo using an immunotoxin
84. Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines
85. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin
86. Routing of internalized ricin and ricin conjugates to the Golgi complex